Ibrutinib treatment and egfr-mutant lung adenocarcinoma

Katerina Shulman; Olga Kazarin; Elias Tannous; Orit Sofer

Ibrutinib treatment and egfr-mutant lung adenocarcinoma

Katerina Shulman, Olga Kazarin, Elias Tannous, Orit Sofer

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	385-386
Number of pages	2
Journal	Israel Medical Association Journal
Volume	23
Issue number	7
State	Published - 1 Jun 2021
Externally published	Yes

Keywords

Adenocarcinoma
Epithelial growth factor receptor (EGFR)
Ibrutinib
Lung

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{f5c6411b49164071afef4ba8c04fcf1d,

title = "Ibrutinib treatment and egfr-mutant lung adenocarcinoma",

keywords = "Adenocarcinoma, Epithelial growth factor receptor (EGFR), Ibrutinib, Lung",

author = "Katerina Shulman and Olga Kazarin and Elias Tannous and Orit Sofer",

year = "2021",

month = jun,

day = "1",

language = "English",

volume = "23",

pages = "385--386",

journal = "Israel Medical Association Journal",

issn = "1565-1088",

publisher = "Israel Medical Association",

number = "7",

}

TY - JOUR

T1 - Ibrutinib treatment and egfr-mutant lung adenocarcinoma

AU - Shulman, Katerina

AU - Kazarin, Olga

AU - Tannous, Elias

AU - Sofer, Orit

PY - 2021/6/1

Y1 - 2021/6/1

KW - Adenocarcinoma

KW - Epithelial growth factor receptor (EGFR)

KW - Ibrutinib

KW - Lung

UR - https://www.scopus.com/pages/publications/85108998941

M3 - Comment/debate

C2 - 34155856

AN - SCOPUS:85108998941

SN - 1565-1088

VL - 23

SP - 385

EP - 386

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

IS - 7

ER -

Ibrutinib treatment and egfr-mutant lung adenocarcinoma

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this